This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Folliculin-interacting protein 2.
Acts as a co-chaperone of HSP90AA1.
Inhibits the ATPase activity of HSP90AA1 leading to decrease in its chaperone action.Facilitates the binding of client protein FLCN to HSP90AA1 (PubMed:27353360). May play a role in the signal transduction pathway of apoptosis induced by O6-methylguanine- mispaired lesions (By similarity).
Human | |
---|---|
Gene Name: | FNIP2 |
Uniprot: | Q9P278 |
Entrez: | 57600 |
Belongs to: |
---|
FNIP family |
FNIP1-like protein; FNIPL; folliculin interacting protein 2
Mass (kDA):
122.115 kDA
Human | |
---|---|
Location: | 4q32.1 |
Sequence: | 4; NC_000004.12 (158769026..158908050) |
Widely expressed with highest levels in muscle, nasal mucosa, salivary gland, uvula, fat, liver, heart, placenta and pancreas. Moderately expressed in the lung, small intestine, kidney and brain. Lower levels detected in renal cell carcinoma than in normal kidney tissue (PubMed:18403135). Higher levels detected in oncocytoma tumors than in normal kidney. Higher levels detected in renal cell carcinoma tumors than in normal kidney tissue (PubMed:27353360).
Cytoplasm. Colocalizes with FLCN in the cytoplasm.
PMID: 18403135 by Hasumi H., et al. Identification and characterization of a novel folliculin-interacting protein FNIP2.
PMID: 18663353 by Takagi Y., et al. Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.